Cefetamet pivoxil
Alternative Names: Cefyl; Globocef; RO 158075Latest Information Update: 08 Aug 2007
At a glance
- Originator Takeda
- Developer Roche; Takeda
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Bacterial infections
Most Recent Events
- 08 Aug 2007 Discontinued - Phase-I for Bacterial infections in USA (PO)
- 12 Jun 2000 Profile reviewed but no significant changes made
- 24 Nov 1997 Launched for Bacterial infections in Indonesia (PO)